Your Location：
Home >
Browse articles >
Gastrodin Inhibits Non-alcoholic Fatty Liver Disease via Mediating SREBP1c Signaling Pathway
Updated：2024-04-30
Previous|Next

    • Gastrodin Inhibits Non-alcoholic Fatty Liver Disease via Mediating SREBP1c Signaling Pathway

    • ZHANG Menglian , ZHANG Yaowen , TANG Linfeng , GONG Zaipeng , HAN Lan , WANG Dandan
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 11, Pages: 70-77(2024)

    • DOI： 10.13422/j.cnki.syfjx.20240504     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 7 ) Tabs( 8 )

  • References

  • Publication Info

  • Metrics

307

Views

285

Downloads

4

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Effect of Danggui Shaoyaosan on TLR4/MyD88/JNK Signaling Pathway on Rats with Nonalcoholic Fatty Liver Disease
Liver with Liver Stagnation and Spleen Deficiency Syndrome and Intestinal Microflora
Clinical Efficacy of Yinchenhao Tang Combined with Sinisan in Treating Nonalcoholic Fatty Liver Disease with Hyperhomocysteinemia
Comparison of in Vitro Dissolution of Active Ingredients in Gastrodiae Rhizoma Powder with Different Particle Size
Traditional Chinese Medicine Treatment of Colorectal Cancer Based on AMPK Signaling Pathway： A Review

Related Author

Yi-shui LI
Xin-qiao CHU
Ya-ning BIAO
Mu-qing ZHANG
Yi-lu HAN
Zi-xuan LI
Yi-xin ZHANG
Wei-ning XIE

Related Institution

School of Pharmacy， Application Technology Research Center of Traditional Chinese Medicine （TCM）Prescription in University of Hebei Province，Hebei University of Chinese Medicine
Guang'anmen Hospital， China Academy of Chinese Medical Sciences
Hebei Provincial Hospital of TCM
Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Beijing Shichahai Community Health Service Center